These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 13342212)

  • 41. The action of lysergic acid diethyl-amide on mammalian cholinesterases.
    THOMPSON RH; TICKNER A; WEBSTER GR
    Br J Pharmacol Chemother; 1955 Mar; 10(1):61-5. PubMed ID: 14351688
    [No Abstract]   [Full Text] [Related]  

  • 42. The CNS action of d-lysergic acid diethylamide (L.S.D.-25).
    SMITH R
    Mod Hosp; 1953 Jan; 80(1):106-10. PubMed ID: 13025280
    [No Abstract]   [Full Text] [Related]  

  • 43. LYSERGIC ACID DIETHYLAMIDE (LSD-25). XXXV. COMPARISON OF EFFECT ON SIAMESE FIGHTING FISH AND GOLDFISH.
    GETTNER HH; ROLO A; ABRAMSON HA
    J Psychol; 1964 Jul; 58():57-63. PubMed ID: 14163636
    [No Abstract]   [Full Text] [Related]  

  • 44. Psychophysiologic variables in the study of the effect of LSD-25 on cerebral blood flow and metabolism.
    PERLIN S
    Psychiatr Res Rep Am Psychiatr Assoc; 1956 Feb; (3):10-4. PubMed ID: 13310662
    [No Abstract]   [Full Text] [Related]  

  • 45. Diethylamine of lysergic acid and its reaction to 5-hydroxytryptamine catalepsy in dog.
    SACCHI U; BONAMINI F; DOLCE G; GARELLO L
    Boll Soc Ital Biol Sper; 1955 Jun; 31(6):665-7. PubMed ID: 13269564
    [No Abstract]   [Full Text] [Related]  

  • 46. The effects of lysergic acid diethylamide on the excitability cycle of the lateral geniculate.
    EVARTS EV; MARSHALL WH
    Trans Am Neurol Assoc; 1955-1956; (80th Meeting):58-60. PubMed ID: 13312000
    [No Abstract]   [Full Text] [Related]  

  • 47. New blocking agent against the development of LSD-25 psychosis.
    FABING HD
    Science; 1955 Feb; 121(3137):208-10. PubMed ID: 13237971
    [No Abstract]   [Full Text] [Related]  

  • 48. Electrophysiological analysis of psychotogenic drug action. I. Effect of LSD on specific afferent systems in the cat.
    PURPURA DP
    AMA Arch Neurol Psychiatry; 1956 Feb; 75(2):122-31. PubMed ID: 13282532
    [No Abstract]   [Full Text] [Related]  

  • 49. The cerebral electrographic changes induced by LSD and mescaline are corrected by frenquel.
    RINALDI F; HIMWICH HE
    J Nerv Ment Dis; 1955 Nov; 122(5):424-32. PubMed ID: 13320138
    [No Abstract]   [Full Text] [Related]  

  • 50. Inhibition of neurotransmitter receptor binding by ergot derivatives.
    Hruska RE; Silbergeld EK
    J Neurosci Res; 1981; 6(1):1-11. PubMed ID: 6111611
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of the d-lysergic acid diethylamide on the psychic functions and on electroencephalogram.
    GASTAUT H; FERRER S; CASTELLS C; LESEVRE N; LUSCHNAT K
    Confin Neurol; 1953; 13(2):102-20. PubMed ID: 13060015
    [No Abstract]   [Full Text] [Related]  

  • 52. Frenquel, a blocking agent against experimental LSD-25 and mescaline psychosis; preliminary note on its clinical application.
    FABING HD
    Neurology; 1955 May; 5(5):319-28. PubMed ID: 14370384
    [No Abstract]   [Full Text] [Related]  

  • 53. Mescaline and LSD-25 in activation of temporal lobe epilepsy.
    SCHWARZ BE; BICKFORD RG; MULDER DW; ROME HP
    Neurology; 1956 Apr; 6(4):275-80. PubMed ID: 13309607
    [No Abstract]   [Full Text] [Related]  

  • 54. [Role of the nervous system in sympatholytic action of Claviceps purpurea alkaloids].
    FALL S; KELEMAN A; OBAL F
    Acta Physiol Acad Sci Hung; 1955; 7(3):223-7. PubMed ID: 13248576
    [No Abstract]   [Full Text] [Related]  

  • 55. [Studies on the mechanism of lysergic acid diethylamide. I].
    ARNOLD OH; HOFF H
    Wien Z Nervenheilkd Grenzgeb; 1953; 6(2-3):129-50. PubMed ID: 13078602
    [No Abstract]   [Full Text] [Related]  

  • 56. Electroencephalographic effects of intraventricular 5-HT and LSD in the cat.
    VOGT M; GUNN CG; SAWYER CH
    Neurology; 1957 Aug; 7(8):559-66. PubMed ID: 13451892
    [No Abstract]   [Full Text] [Related]  

  • 57. [Body scheme disorders in lysergic acid diethylamide].
    ARNOLD OH; HOFF H
    Wien Z Nervenheilkd Grenzgeb; 1953; 6(4):259-74. PubMed ID: 13078611
    [No Abstract]   [Full Text] [Related]  

  • 58. Lowered capillary resistance after iontophoresis of lysergic acid diethylamide.
    BLAIR EL; WAKEFIELD M; INGRAM GI; ARMITAGE P
    Nature; 1955 Sep; 176(4481):563. PubMed ID: 13265778
    [No Abstract]   [Full Text] [Related]  

  • 59. Some effects of lysergic acid diethylamide and bufotenine on electrical activity in the cat's visual system.
    EVARTS EV; LANDAU W; FREYGANG W; MARSHALL WH
    Am J Physiol; 1955 Sep; 182(3):594-8. PubMed ID: 13258860
    [No Abstract]   [Full Text] [Related]  

  • 60. Effects of mescaline, LSD-25, and adrenochrome on depth electrograms in man.
    SCHWARZ BE; SEM-JACOBSEN CW; PETERSEN MC
    AMA Arch Neurol Psychiatry; 1956 Jun; 75(6):579-87. PubMed ID: 13325988
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.